{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2012-N-1037\" sorted by posted_date descending", "rows": [["FDA-2012-N-1037-0107", "FDA", "FDA-2012-N-1037", "Reference 76 - Meyer, J. M., N. P. Silliman, W. Wang, et al.. \u201cRisk Factors for Helicobacter pylori Resistance in the United States - Establishing a List of Qualifying Pathogens Under the Food and  Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:47:39Z", null, 0, 0, "090000648172c518"], ["FDA-2012-N-1037-0124", "FDA", "FDA-2012-N-1037", "Reference 93 - Ribes, J. A., C. L. Vanover-Sams, and D. J. Baker, \u201cZygomycetes in Human Disease,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:15:57Z", null, 0, 0, "090000648172c529"], ["FDA-2012-N-1037-0084", "FDA", "FDA-2012-N-1037", "Reference 53 - Chayakulkeeree, M., J. R. Perfect, \u201cCryptococcosis,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:02:49Z", null, 0, 0, "090000648172c501"], ["FDA-2012-N-1037-0101", "FDA", "FDA-2012-N-1037", "Reference 70 - Rosenberg, J. J., \u201cHelicobacter pylori,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:41:30Z", null, 0, 0, "090000648172c512"], ["FDA-2012-N-1037-0103", "FDA", "FDA-2012-N-1037", "Reference 72 - De Francesco, V., A. Zullo, C. Hassan, et al., \u201cMechanisms of Helicobacter pylori Antibiotic Resistance: An Updated Appraisal,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:46:56Z", null, 0, 0, "090000648172c514"], ["FDA-2012-N-1037-0125", "FDA", "FDA-2012-N-1037", "Reference 94 - Rees, J. R., R. W. Pinner, R. A. Hajjeh, et al., \u201cThe Epidemiologic Features of Invasive Mycotic Infection in the San Francisco Bay Area 1992-1993: Results of a Population-Based Laboratory Active Surveillance,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:48:45Z", null, 0, 0, "090000648172c52a"], ["FDA-2012-N-1037-0085", "FDA", "FDA-2012-N-1037", "Reference 54 - Centers for Disease Control and Prevention, \u201cC. neoformans cryptococcosis: Cryptococcosis Statistics\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:03:01Z", null, 0, 0, "090000648172c502"], ["FDA-2012-N-1037-0091", "FDA", "FDA-2012-N-1037", "Reference 60 - Harris, J. R., S. R. Lockhart, E. Debess, et al., \u201cCryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:13:08Z", null, 0, 0, "090000648172c508"], ["FDA-2012-N-1037-0104", "FDA", "FDA-2012-N-1037", "Reference 73 -  De Francesco, V., F. Giorgio, C. Hassan, et al., \u201cWorldwide H. pylori Antibiotic Resistance: A Systematic Review,\u201d Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:47:12Z", null, 0, 0, "090000648172c515"], ["FDA-2012-N-1037-0117", "FDA", "FDA-2012-N-1037", "Reference 86 - Mayers, D., Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:11:46Z", null, 0, 0, "090000648172c522"], ["FDA-2012-N-1037-0118", "FDA", "FDA-2012-N-1037", "Reference 87 - Cortez, K., E. Roilides, F. Quiroz-Telles, et al., Infections Caused By Scedosporium spp - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:12:07Z", null, 0, 0, "090000648172c523"], ["FDA-2012-N-1037-0078", "FDA", "FDA-2012-N-1037", "Reference 47 - CDC Features, \u201cValley Fever: Awareness is Key\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:01:32Z", null, 0, 0, "090000648172c0fb"], ["FDA-2012-N-1037-0075", "FDA", "FDA-2012-N-1037", "Reference 44 - Centers for Disease Control and Prevention, \u201cIncrease in Reported Coccidioidomycosis--United States, 1998-2011,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:23:21Z", null, 0, 0, "090000648172c0f8"], ["FDA-2012-N-1037-0089", "FDA", "FDA-2012-N-1037", "Reference 58 - Upton, A., J.A. Fraser, S.E. Kidd, et. al., \u201cFirst Contemporary Case of Human Infection with Cryptococcus Gattii in Puget Sound: Evidence for Spread of the Vancouver Island Outbreak,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:12:39Z", null, 0, 0, "090000648172c506"], ["FDA-2012-N-1037-0093", "FDA", "FDA-2012-N-1037", "Reference 62 - Pfaller, M. A., D. J. Diekema, D. L. Gibbs, et al., \u201cResults from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007 - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:13:40Z", null, 0, 0, "090000648172c50a"], ["FDA-2012-N-1037-0113", "FDA", "FDA-2012-N-1037", "Reference 82 - Murdock, D. A., \u201cGram-Positive Anaerobic Cocci,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:59:46Z", null, 0, 0, "090000648172c51e"], ["FDA-2012-N-1037-0121", "FDA", "FDA-2012-N-1037", "Reference 90 - Song, M. J., J. H. Lee, and N. Y. Lee, \u201cFatal Scedosporium prolificans Infection in a Paediatric Patient with Acute Lymphoblastic Leukaemia,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:13:58Z", null, 0, 0, "090000648172c526"], ["FDA-2012-N-1037-0129", "FDA", "FDA-2012-N-1037", "Reference 98 -  Centers for Disease Control and Prevention, \u201cC. gattii Cryptococcosis Statistics\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:49:52Z", null, 0, 0, "090000648172c52e"], ["FDA-2012-N-1037-0122", "FDA", "FDA-2012-N-1037", "Reference 91 - Munoz, P., M. Marin, P. Tornero, et al., \u201cSuccessful Outcome of Scedosporium apiospermum Disseminated Infection Treated with Voriconazole in a Patient Receiving Corticosteroid Therapy,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:14:15Z", null, 0, 0, "090000648172c527"], ["FDA-2012-N-1037-0127", "FDA", "FDA-2012-N-1037", "Reference 96 - Neofytos, D., D. Horn, E. Anaissie, et al., \u201cEpidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:49:31Z", null, 0, 0, "090000648172c52c"], ["FDA-2012-N-1037-0070", "FDA", "FDA-2012-N-1037", "Reference 39 - Leal, J., D. B. Gregson, T. Ross, et al., \u201cEpidemiology of Clostridium Species Bacteremia in Calgary, Canada, 2000-2006,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:22:28Z", null, 0, 0, "090000648172c0f3"], ["FDA-2012-N-1037-0094", "FDA", "FDA-2012-N-1037", "Reference 63 - Gast, C. E, L. R. Basso Jr., I. Bruzual, et al., \u201cAzole Resistance in Cryptococcus gattii from the Pacific Northwest: Investigation of the Role of ERG11,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:13:51Z", null, 0, 0, "090000648172c50b"], ["FDA-2012-N-1037-0095", "FDA", "FDA-2012-N-1037", "Reference 64 - Nir-Paz, R., J. Strahilevitz, M. Shapiro, et al., \u201cClinical and Epidemiological Aspects of Infection Caused By Fusarium Species: a Collaborative Study From Israel,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:14:05Z", null, 0, 0, "090000648172c50c"], ["FDA-2012-N-1037-0099", "FDA", "FDA-2012-N-1037", "Reference 68 - Centers for Disease Control and Prevention, \u201cHelicobacter pylori: Fact Sheet for Health Care Professionals,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:26:21Z", null, 0, 0, "090000648172c510"], ["FDA-2012-N-1037-0100", "FDA", "FDA-2012-N-1037", "Reference 69 - Seck, A., C. Burucoa, D. Dia, et al., \u201cPrimary Antibiotic Resistance and Associated Mechanisms in Helicobacter pylori Isolates from Senegalese Patients,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:31:04Z", null, 0, 0, "090000648172c511"], ["FDA-2012-N-1037-0109", "FDA", "FDA-2012-N-1037", "Reference 78 - Costello, A., G. Herbert, L. Fabunmi, et al. \u201cVirulence of an Emerging Respiratory Pathogen, Genus Pandoraea, in vivo and its Interactions with Lung Epithelial Cells,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:51:59Z", null, 0, 0, "090000648172c51a"], ["FDA-2012-N-1037-0126", "FDA", "FDA-2012-N-1037", "Reference 95 - Marr, K. A., R. A. Carter, F. Crippa, et al., \u201cEpidemiology and Outcome of Mold Infections in Hematopoietic Stem Cell Transplant Recipients,\u201d  Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:49:15Z", null, 0, 0, "090000648172c52b"], ["FDA-2012-N-1037-0128", "FDA", "FDA-2012-N-1037", "Reference 97 - Bayram, Y., H. Korkoca, C. Aypak, et al., \u201cAntimicrobial Susceptibilities of Brucella Isolates from Various Clinical Specimens,\u201d  - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:51:04Z", null, 0, 0, "090000648172c52d"], ["FDA-2012-N-1037-0092", "FDA", "FDA-2012-N-1037", "Reference 61- Perfect, J. R., W. E. Dismukes, F. Dromer, et al., \u201cClinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:13:30Z", null, 0, 0, "090000648172c509"], ["FDA-2012-N-1037-0096", "FDA", "FDA-2012-N-1037", "Reference 65 - Al-Abdely, H. M., \u201cManagement of Rare Fungal Infections,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:14:17Z", null, 0, 0, "090000648172c50d"], ["FDA-2012-N-1037-0110", "FDA", "FDA-2012-N-1037", "Reference 79 - Schneider, I. and A. Bauernfeind, \u201cIntrinsic Carbapenem-Hydrolysing Oxacillinases of Pandoraea species-- A Tool for Species Identification?,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:52:51Z", null, 0, 0, "090000648172c51b"], ["FDA-2012-N-1037-0111", "FDA", "FDA-2012-N-1037", "Reference 80 - LiPuma, J., \u201cThe Changing Microbial Epidemiology in Cystic Fibrosis,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:53:19Z", null, 0, 0, "090000648172c51c"], ["FDA-2012-N-1037-0116", "FDA", "FDA-2012-N-1037", "Reference 85 - Brazier, J. S., V. Hall, T. E. Morris, et al., \u201cAntibiotic Susceptibilities of Gram-Positive Anaerobic Cocci: Results of a Sentinel Study in England and Wales,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:11:32Z", null, 0, 0, "090000648172c521"], ["FDA-2012-N-1037-0123", "FDA", "FDA-2012-N-1037", "Reference 92 - Rogers, T. R., \u201cTreatment of Zygomycosis: Current and New Options,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:14:59Z", null, 0, 0, "090000648172c528"], ["FDA-2012-N-1037-0073", "FDA", "FDA-2012-N-1037", "Reference 42 - Soge, O. O., L. D. Tivoli, J. S. Meschke, et al., \u201cA Conjugative Macrolide Resistance Gene, mef(A), in Environmental Clostridium perfringens Carrying Multiple Macrolide and/or Tetracycline Resistance Genes,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:22:59Z", null, 0, 0, "090000648172c0f6"], ["FDA-2012-N-1037-0071", "FDA", "FDA-2012-N-1037", "Reference 40 - Tansuphasiri, U., W. Matra, and L. Sangsuk, \u201cAntimicrobial Resistance among Clostridium perfringens Isolated from Various Sources in Thailand,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:22:37Z", null, 0, 0, "090000648172c0f4"], ["FDA-2012-N-1037-0072", "FDA", "FDA-2012-N-1037", "Reference 41- Bannam, T. L., W. L. Teng, D. Bulach, et al., \u201cFunctional Identification of Conjugation and Replication Regions of the Tetracycline Resistance Plasmid pCW3 from Clostridium perfringens,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:22:46Z", null, 0, 0, "090000648172c0f5"], ["FDA-2012-N-1037-0076", "FDA", "FDA-2012-N-1037", "Reference 45 -  Galgiani, J. N., N. M. Ampel, J. E. Blair, et al., \u201cCoccidioidomycosis,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:23:35Z", null, 0, 0, "090000648172c0f9"], ["FDA-2012-N-1037-0069", "FDA", "FDA-2012-N-1037", "Reference 38 - Lee, Y., Y. Park., M. S. Kim, et al., \u201cAntimicrobial Susceptibility Patterns for Recent Clinical Isolates of Anaerobic Bacteria in South Korea,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:22:01Z", null, 0, 0, "090000648172c0f2"], ["FDA-2012-N-1037-0105", "FDA", "FDA-2012-N-1037", "Reference 74 - Megraud, F., S. Coenen, A. Versporten, et al., \u201cHelicobacter pylori Resistance to Antibiotics in Europe and its Relationship to Antibiotic Consumption,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:47:21Z", null, 0, 0, "090000648172c516"], ["FDA-2012-N-1037-0119", "FDA", "FDA-2012-N-1037", "Reference 88- Cremer, G. and P. Boirin, \u201cScedosporium Species: The Rising Importance of Newly Emerging Fungal Pathogens,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:12:33Z", null, 0, 0, "090000648172c524"], ["FDA-2012-N-1037-0120", "FDA", "FDA-2012-N-1037", "Reference 89 -  Cooley, L., D. Spelman, K. Thursky, et al., \u201cInfection with Scedosporium apiospermum and S. prolificans, Australia,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:13:27Z", null, 0, 0, "090000648172c525"], ["FDA-2012-N-1037-0088", "FDA", "FDA-2012-N-1037", "Reference 57 - Iqbal, N., E. E. DeBess, R. Wohrle, et al., \u201cCorrelation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:12:26Z", null, 0, 0, "090000648172c505"], ["FDA-2012-N-1037-0108", "FDA", "FDA-2012-N-1037", "Reference  77 - Megraud, F., \u201cThe Challenge of Helicobacter pylori Resistance to Antibiotics: The Comeback of Bismuth-Based Quadruple Therapy,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:48:14Z", null, 0, 0, "090000648172c519"], ["FDA-2012-N-1037-0112", "FDA", "FDA-2012-N-1037", "Reference 81 - J\u00f8rgensen, I. M., H. K. Johansen, B. Frederiksen, et al., \u201cEpidemic Spread of Pandoreaea apista, a New Pathogen Causing Severe Lung Disease in Cystic Fibrosis Patients,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:57:09Z", null, 0, 0, "090000648172c51d"], ["FDA-2012-N-1037-0115", "FDA", "FDA-2012-N-1037", "Reference 84 -  Koeth, L. M., C. E. Good, P. C. Appelbaum, et al., Surveillance of Susceptibility Patterns - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-09T01:11:10Z", null, 0, 0, "090000648172c520"], ["FDA-2012-N-1037-0074", "FDA", "FDA-2012-N-1037", "Reference 43 -Centers for Disease Control and Prevention, \u201cDefinition of\nCoccidioidomycosis (Valley Fever),\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T20:23:11Z", null, 0, 0, "090000648172c0f7"], ["FDA-2012-N-1037-0077", "FDA", "FDA-2012-N-1037", "Reference 46 - Centers for Disease Control and Prevention, \u201cSummary of Notifiable Diseases--United States, 2009,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:01:01Z", null, 0, 0, "090000648172c0fa"], ["FDA-2012-N-1037-0079", "FDA", "FDA-2012-N-1037", "Reference 48 - Iowa State University, The Center for Food Security & Public Health, \u201cCoccidioidomycosis,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:01:43Z", null, 0, 0, "090000648172c0fc"], ["FDA-2012-N-1037-0081", "FDA", "FDA-2012-N-1037", "Reference 50 - Huang, J. Y, B. Bristow, S. Shafir, and F.Sorvillo. Coccidioidomycosis- Associated Deaths - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:02:03Z", null, 0, 0, "090000648172c0fe"], ["FDA-2012-N-1037-0082", "FDA", "FDA-2012-N-1037", "Reference 51 - Kriesel, J. D., D. A. Sutton, S. Schulman, et al., \u201cPersistent Pulmonary Infection with an Azole-Resistant Coccidioides Species,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:02:15Z", null, 0, 0, "090000648172c0ff"], ["FDA-2012-N-1037-0083", "FDA", "FDA-2012-N-1037", "Reference 52 - Mathisen, G., A. Shelub, J. Truong, and C. Wigen, \u201cCoccidioidal Meningitis: Clinical Presentation and Management in the Fluconazole Era,\u201d -Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:02:40Z", null, 0, 0, "090000648172c500"], ["FDA-2012-N-1037-0087", "FDA", "FDA-2012-N-1037", "Reference 56 - Pfaller, M.A. and D. J. Diekema, \u201cEpidemiology of Invasive Mycoses in North America,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:12:12Z", null, 0, 0, "090000648172c504"], ["FDA-2012-N-1037-0097", "FDA", "FDA-2012-N-1037", "Reference 66 - Cave, D. R., \u201cHow is Helicobacter pylori Transmitted?,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:19:14Z", null, 0, 0, "090000648172c50e"], ["FDA-2012-N-1037-0098", "FDA", "FDA-2012-N-1037", "Reference 67 - Duck, W. M., J. Sobel, J. M. Prucker, et al., \u201cAntimicrobial Resistance Incidence and Risk Factors Among Helicobacter pylori-Infected Persons, United States,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:23:36Z", null, 0, 0, "090000648172c50f"], ["FDA-2012-N-1037-0102", "FDA", "FDA-2012-N-1037", "Reference 71 -  Everhart, J. E., D. Kruszon-Moran, G. I. Perez-Perez, et al., \u201cSeroprevalence and Ethnic Difference in Helicobacter pylori Infection Among Adults in the United States,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:45:27Z", null, 0, 0, "090000648172c513"], ["FDA-2012-N-1037-0114", "FDA", "FDA-2012-N-1037", "Reference 83 - Ryan, K. J. and C. G. Ray, Sherris Medical Microbiology: An Introduction to Infectious Disease, McGraw-Hill, New York, 4th Ed., 2004. - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T23:04:06Z", null, 0, 0, "090000648172c51f"], ["FDA-2012-N-1037-0086", "FDA", "FDA-2012-N-1037", "Reference 55 - Pyrgos, V., A. E. Seitz, C. A. Steiner, et al., \u201cEpidemiology of Cryptococcal Meningitis in the US: 1997-2009,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:12:02Z", null, 0, 0, "090000648172c503"], ["FDA-2012-N-1037-0090", "FDA", "FDA-2012-N-1037", "Reference 59 - Duggan, J. and H. M. Walls, \"Ocular Complications of Cryptococcal Meningitis in Patients with HIV,\" - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:12:54Z", null, 0, 0, "090000648172c507"], ["FDA-2012-N-1037-0106", "FDA", "FDA-2012-N-1037", "Reference 75 - Gao, W., H. Cheng, F. Hu, et al., \u201cThe Evolution of Helicobacter pylori Antibiotics Resistance Over 10 years in Beijing, China,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T22:47:30Z", null, 0, 0, "090000648172c517"], ["FDA-2012-N-1037-0080", "FDA", "FDA-2012-N-1037", "Reference 49 - Tsang, C. A., S. M. Anderson, S. B. Imholte, et al., \u201cEnhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007-2008.\u201d  Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-08T04:00:00Z", 2014, 6, null, null, "2014-06-08T21:01:51Z", null, 0, 0, "090000648172c0fd"], ["FDA-2012-N-1037-0068", "FDA", "FDA-2012-N-1037", "Reference 37 - Wybo, I., et al., \u201cThird Belgian Multicentre Survey of Antibiotic Susceptibility of Anaerobic Bacteria,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-06T04:00:00Z", 2014, 6, null, null, "2014-06-06T19:08:06Z", null, 0, 0, "090000648172c0f1"], ["FDA-2012-N-1037-0067", "FDA", "FDA-2012-N-1037", "Reference 36 -  Hall, A. J., A. T. Curns, L. C. McDonald, et al., \u201cThe Roles of Clostridium difficile and Norovirus Among Gastroenteritis-Associated Deaths in the United States, 1999-2007,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-06T04:00:00Z", 2014, 6, null, null, "2014-06-06T18:58:06Z", null, 0, 0, "090000648172c0f0"], ["FDA-2012-N-1037-0033", "FDA", "FDA-2012-N-1037", "Reference 2 - Howard, D. H., R. D. Scott II, R. Packard, et al., \u201cThe Global Impact of Drug Resistance\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T02:47:52Z", null, 0, 0, "090000648172c028"], ["FDA-2012-N-1037-0036", "FDA", "FDA-2012-N-1037", "Reference 5 - Wong, M. R., V. Reddy, H. Hanson, et al., \u201cAntimicrobial Resistance Trends of Shigella Serotypes in New York City, 2006-2009 - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:00:33Z", null, 0, 0, "090000648172c02b"], ["FDA-2012-N-1037-0039", "FDA", "FDA-2012-N-1037", "Reference 8 - Shah, H. N., I. Olsen, K. Bernard, et al., \u201cApproaches to the Study of the Systematics of Anaerobic, Gram-negative, Non-sporeforming Rods: Current Status and Perspectives,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:01:23Z", null, 0, 0, "090000648172c02e"], ["FDA-2012-N-1037-0040", "FDA", "FDA-2012-N-1037", "Reference 9 - Feingold, S. M., Microbiology. 4th Ed. Galveston: University of Texas Medical Branch at Galveston, 1996, Ch. 20 - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:01:58Z", null, 0, 0, "090000648172c0d5"], ["FDA-2012-N-1037-0051", "FDA", "FDA-2012-N-1037", "Reference 20 - Centers for Disease Control and Prevention, \u201cBioterrorism Agents/Diseases\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:05:10Z", null, 0, 0, "090000648172c0e0"], ["FDA-2012-N-1037-0055", "FDA", "FDA-2012-N-1037", "Reference 24 - Tanyele, E., A. Y. Coban, S. T. Koruk, et al., \u201cActual Antibiotic Resistance Pattern of Brucella melitensis in Central Anatolia: An Update From and Endemic Region,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:06:23Z", null, 0, 0, "090000648172c0e4"], ["FDA-2012-N-1037-0062", "FDA", "FDA-2012-N-1037", "Reference 31- Roach, R. L. and D. G. Sienko, \u201cClostridium perfringens Outbreak Associated with Minestrone Soup,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:08:34Z", null, 0, 0, "090000648172c0eb"], ["FDA-2012-N-1037-0056", "FDA", "FDA-2012-N-1037", "Reference 25 - Parlak, M., H. G\u00fcd\u00fcc\u00fco\u011flu, Y. Bayram, et al., \u201cIdentification and Determination of Antibiotic Susceptibilities of Brucella Strains Isolated from Patients in Van, Turkey by Conventional and Molecular Methods - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:06:37Z", null, 0, 0, "090000648172c0e5"], ["FDA-2012-N-1037-0043", "FDA", "FDA-2012-N-1037", "Reference 12 - Goldstein, E. J. C., D. M. Citron, S. A. Vaidya, et al., \u201cIn Vitro Activity of 11 Antibiotics Against 74 Anaerobes Isolated from Pediatric Intra-abdominal Infections,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:02:39Z", null, 0, 0, "090000648172c0d8"], ["FDA-2012-N-1037-0057", "FDA", "FDA-2012-N-1037", "Reference 26 - Maves, R. C., R. Castillo, A. Guillen, et al., \u201cAntimicrobial Susceptibility of Brucella melitensis Isolates in Peru,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:06:55Z", null, 0, 0, "090000648172c0e6"], ["FDA-2012-N-1037-0064", "FDA", "FDA-2012-N-1037", "Reference 33 - Stevens, D. L., M. J. Aldape, and A. E. Bryant, \u201cLife-threatening Clostridial Infections,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:09:01Z", null, 0, 0, "090000648172c0ed"], ["FDA-2012-N-1037-0052", "FDA", "FDA-2012-N-1037", "Reference 21 - Pappas, G., N. Akritidis, M. Bosilkovski, et al., \u201cBrucellosis,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:05:25Z", null, 0, 0, "090000648172c0e1"], ["FDA-2012-N-1037-0048", "FDA", "FDA-2012-N-1037", "Reference 17 - Summary of Notifiable Diseases--United States, 2006 - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:04:07Z", null, 0, 0, "090000648172c0dd"], ["FDA-2012-N-1037-0042", "FDA", "FDA-2012-N-1037", "Reference 11 - Lassmann, B., D. R. Gustafson, C. M. Wood, and J. E. Rosenblatt, \u201cReemergence of Anaerobic Bacteremia,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:02:26Z", null, 0, 0, "090000648172c0d7"], ["FDA-2012-N-1037-0058", "FDA", "FDA-2012-N-1037", "Reference  27 - Centers for Disease Control and Prevention, \u201cHealthcare-associated Infections: Clostridium sordellii\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:07:13Z", null, 0, 0, "090000648172c0e7"], ["FDA-2012-N-1037-0047", "FDA", "FDA-2012-N-1037", "Reference 16 - Liu, C. Y., Y. T. Huang, C. H. Liao, et al., \u201cIncreasing Trends in\nAntimicrobial Resistance among Clinically Important Anaerobes and Bacteroides fragilis Isolates Causing Nosocomial Infections: Emerging Resistance to Carbapenems,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:03:54Z", null, 0, 0, "090000648172c0dc"], ["FDA-2012-N-1037-0046", "FDA", "FDA-2012-N-1037", "Reference 15 - Teng, L. J., P. R. Hsueh, J. C. Tsai, et al., \u201cHigh Incidence of Cefoxitin and Clindamycin Resistance among Anaerobes in Taiwan,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:03:37Z", null, 0, 0, "090000648172c0db"], ["FDA-2012-N-1037-0032", "FDA", "FDA-2012-N-1037", "Reference 1- Roberts, R. R., B. Hota, I. Ahmad, et al., \u201cHospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship,\u201d Clinical Infectious Diseases, 2009;49:1175-1184 - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T02:47:06Z", null, 0, 0, "090000648172c027"], ["FDA-2012-N-1037-0038", "FDA", "FDA-2012-N-1037", "Reference 7 - Mandell, G. L., J. E. Bennett, R. Dolin, et al., Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. 7th Ed. Philadelphia: Churchill Livingstone Elsevier, 2010 - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:01:02Z", null, 0, 0, "090000648172c02d"], ["FDA-2012-N-1037-0053", "FDA", "FDA-2012-N-1037", "Reference 22 - Abdel-Maksoud, M., B. House, M. Wasfy, et al., \u201cIn Vitro Antibiotic Susceptibility Testing of Brucella Isolates from Egypt between 1999 and 2007 and Evidence of Probable Rifampin Resistance,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:05:38Z", null, 0, 0, "090000648172c0e2"], ["FDA-2012-N-1037-0044", "FDA", "FDA-2012-N-1037", "Reference 13 - Jamal W., M. Shahin, and V. O. Rotimi, \u201cSurveillance and Trends of Antimicrobial Resistance Among Clinical Isolates of Anaerobes in Kuwait Hospitals from 2002 to 2007,\u201d  - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:02:54Z", null, 0, 0, "090000648172c0d9"], ["FDA-2012-N-1037-0050", "FDA", "FDA-2012-N-1037", "Reference 19 - Centers for Disease Control and Prevention, \u201cNotifiable Diseases and Mortality Tables,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:04:55Z", null, 0, 0, "090000648172c0df"], ["FDA-2012-N-1037-0060", "FDA", "FDA-2012-N-1037", "Reference 29 -Centers for Disease Control and Prevention, \u201cFood Safety: Clostridium perfringens\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:07:54Z", null, 0, 0, "090000648172c0e9"], ["FDA-2012-N-1037-0045", "FDA", "FDA-2012-N-1037", "Reference 14 - Behra-Miellet, J., L. Calveta, F. Mory, et al., \u201cAntibiotic Resistance Among Anaerobic Gram-negative Bacilli: Lessons from a French Multicentric Survey,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:03:19Z", null, 0, 0, "090000648172c0da"], ["FDA-2012-N-1037-0063", "FDA", "FDA-2012-N-1037", "Reference 32 - Bad Bug Book: Handbook of Foodborne Pathogenic Microorganisms and Natural Toxins - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:08:47Z", null, 0, 0, "090000648172c0ec"], ["FDA-2012-N-1037-0054", "FDA", "FDA-2012-N-1037", "Reference 23 - Kinsara, A., A. Al-Mowallad, and A. O. Osoba, \u201cIncreasing Resistance of Brucellae to Co-Trimoxazole,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:05:55Z", null, 0, 0, "090000648172c0e3"], ["FDA-2012-N-1037-0031", "FDA", "FDA-2012-N-1037", "List of References - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T02:34:50Z", null, 0, 0, "090000648172c026"], ["FDA-2012-N-1037-0049", "FDA", "FDA-2012-N-1037", "Reference 18 - Centers for Disease Control and Prevention, \u201cSummary of Notifiable Diseases--United States, 2008,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:04:29Z", null, 0, 0, "090000648172c0de"], ["FDA-2012-N-1037-0059", "FDA", "FDA-2012-N-1037", "Reference 28 - McGuigan, C. C., G. M. Penrice, L. Gruer, et al., \u201cLethal Outbreak of Infection with Clostridium novyi Type A and Other Spore-Forming Organisms in Scottish Injecting Drug Users,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:07:32Z", null, 0, 0, "090000648172c0e8"], ["FDA-2012-N-1037-0061", "FDA", "FDA-2012-N-1037", "Reference 30 - Wahl, E., S. R\u00f8mma, and P. E. Granum, \u201cA Clostridium perfringens Outbreak Traced to Temperature-Abused Beef Stew, Norway, 2012,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:08:17Z", null, 0, 0, "090000648172c0ea"], ["FDA-2012-N-1037-0037", "FDA", "FDA-2012-N-1037", "Reference 6 - Alcaine, S. D., L. D. Warnick, and M. Wiedmann, \u201cAntimicrobial Resistance in Nontyphoidal Salmonella\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:00:47Z", null, 0, 0, "090000648172c02c"], ["FDA-2012-N-1037-0041", "FDA", "FDA-2012-N-1037", "Reference  10 - Ngo, J. T., M. D. Parkins, D. B. Gregson, et al., \u201cPopulation-based Assessment of the Incidence, Risk Factors, and Outcomes of Anaerobic Bloodstream Infections,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:02:12Z", null, 0, 0, "090000648172c0d6"], ["FDA-2012-N-1037-0065", "FDA", "FDA-2012-N-1037", "Reference 34 - Centers for Disease Control and Prevention, \u201cMaking Healthcare Safer: Stopping C. difficile Infections,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:09:19Z", null, 0, 0, "090000648172c0ee"], ["FDA-2012-N-1037-0066", "FDA", "FDA-2012-N-1037", "Reference 35 - Redelings, M. D., F. Sorvino, and L. Mascola, \u201cIncrease in Clostridium difficile-Related Mortality Rates, United States, 1999-2004,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T03:09:39Z", null, 0, 0, "090000648172c0ef"], ["FDA-2012-N-1037-0034", "FDA", "FDA-2012-N-1037", "Reference 3  Niedell, M. J., B. Cohen, Y. Furuya, et al., \u201cCosts of Healthcare- and Community-Associated Infections With Antimicrobial-Resistant Versus Antimicrobial- Susceptible Organisms\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T02:48:50Z", null, 0, 0, "090000648172c029"], ["FDA-2012-N-1037-0035", "FDA", "FDA-2012-N-1037", "Reference 4 - Sj\u00f6lund Karlsson, M., A. Bowen, R. Reporter, et al., \u201cOutbreak of Infections Caused by Shigella sonnei with Reduced Susceptibility to Azithromycin in the United States,\u201d - Establishing a List of Qualifying Pathogens Under the Food and Drug Administration Safety and Innovation Act", "Supporting & Related Material", "Background Material", "2014-06-05T04:00:00Z", 2014, 6, null, null, "2014-06-06T02:50:04Z", null, 0, 0, "090000648172c02a"], ["FDA-2012-N-1037-0030", "FDA", "FDA-2012-N-1037", "Establishing a List of Qualifying Pathogens Under the Food and Drug\nAdministration Safety and Innovation Act", "Rule", "Final Rule", "2014-06-05T04:00:00Z", 2014, 6, "2014-06-05T04:00:00Z", null, "2014-06-05T14:39:54Z", "2014-13023", 0, 0, "090000648172a9f3"]], "truncated": false, "filtered_table_rows_count": 103, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2012-N-1037"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037", "results": [{"value": "FDA", "label": "FDA", "count": 103, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2012-N-1037", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 99, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&document_type=Other", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037", "results": [{"value": 2014, "label": 2014, "count": 100, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&posted_year=2014", "selected": false}, {"value": 2012, "label": 2012, "count": 2, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&posted_year=2012", "selected": false}, {"value": 2013, "label": 2013, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&posted_year=2013", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_facet_date=last_modified"}], "next": "2014-06-05T04~3A00~3A00Z,FDA-2012-N-1037-0030", "next_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2012-N-1037&_next=2014-06-05T04~3A00~3A00Z%2CFDA-2012-N-1037-0030&_sort_desc=posted_date", "private": false, "allow_execute_sql": true, "query_ms": 84.8655360750854, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}